Pancreatic Cancer Research

ResearcherNational Institutes of HealthNo recent work listed

Fangcheng Yuan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8443-6754; OpenAlex author ID A5012110580. Sources: OpenAlex.

Their work

Papers
5 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
3
Papers, trials and grants by year

2020: 1 paper · 2021: 3 papers · 2022: none · 2023: 1 paper

Papers 5

  1. Autoimmune conditions and pancreatic cancer risk in older American adults. Co-author DOI 10.1002/ijc.34235↗
  2. Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies. First author DOI 10.1093/ajcn/nqab217↗
  3. Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3. Co-author DOI 10.1158/0008-5472.can-20-3267↗
  4. Hemochromatosis, Iron Overload-Related Diseases, and Pancreatic Cancer Risk in the Surveillance, Epidemiology, and End Results (SEER)-Medicare. First author DOI 10.1158/1055-9965.epi-21-0476↗
  5. Genome-Wide Association Study Data Reveal Genetic Susceptibility to Chronic Inflammatory Intestinal Diseases and Pancreatic Ductal Adenocarcinoma Risk. Co-author DOI 10.1158/0008-5472.can-20-0447↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sachelly Julián‐Serrano · 2 shared papers, 2021–2023 · strength 0.38
  2. Rachael Z. Stolzenberg‐Solomon · 2 shared papers, 2021–2023 · strength 0.38
  3. Simran Arjani · 1 shared paper, 2023 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.